Diferencia entre revisiones de «Subdural hemorrhage»
Sin resumen de edición |
(Major expansion: acute vs chronic features, anticoagulation reversal, surgical indications, peer-reviewed references) |
||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*Bleeding between the dura mater and arachnoid membrane, typically from bridging vein rupture | |||
* | *Three types by timing: | ||
* | **'''Acute''' (<3 days) — hyperdense (white) on CT | ||
** | **'''Subacute''' (3-21 days) — isodense (may be difficult to see) | ||
* | **'''Chronic''' (>21 days) — hypodense (dark) on CT | ||
* | *Most common in elderly and anticoagulated patients<ref name="karibe">Karibe H, et al. Surgical management of traumatic acute subdural hematoma in adults. ''Neurol Med Chir (Tokyo)''. 2014;54(11):887-894. PMID 25367584.</ref> | ||
* | *Acute SDH mortality: 50-90% (highest of all traumatic intracranial lesions) | ||
*May occur with minimal or no trauma in the elderly and anticoagulated | |||
==Risk Factors== | |||
*Advanced age (cerebral atrophy stretches bridging veins) | |||
*Anticoagulation / antiplatelet therapy | |||
*Chronic [[Ethanol toxicity|alcohol use]] (cerebral atrophy, coagulopathy) | |||
*Coagulopathy or thrombocytopenia | |||
*Prior falls or head trauma (even minor) | |||
*CSF shunt (overdrainage) | |||
==Clinical Features== | ==Clinical Features== | ||
* | ===Acute SDH=== | ||
* | *Headache, altered mental status, decreasing [[GCS]] | ||
* | *Ipsilateral fixed/dilated pupil (uncal herniation) | ||
*Contralateral hemiparesis | |||
*May present with coma from onset | |||
*Associated with high-energy mechanism or fall in anticoagulated patients | |||
===Chronic SDH=== | |||
*Insidious onset over weeks to months | |||
*Headache, cognitive decline, confusion, personality changes | |||
*Gait disturbance, falls | |||
*Fluctuating neurologic symptoms (may mimic [[Stroke (main)|stroke]] or [[Dementia|dementia]]) | |||
*History of trauma often absent or trivial | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*[[Epidural hemorrhage]] | |||
*[[Subarachnoid hemorrhage]] | |||
*[[Intracerebral hemorrhage]] | |||
*[[Stroke (main)|Ischemic stroke]] | |||
*[[Meningitis]] | |||
*[[Dementia]] (chronic SDH) | |||
==Evaluation== | ==Evaluation== | ||
*'''Non-contrast CT head''' — test of choice<ref name="bullock2">Bullock MR, et al. Surgical management of acute subdural hematomas. ''Neurosurgery''. 2006;58(3 Suppl):S16-24. PMID 16710968.</ref> | |||
**Acute: hyperdense, crescent-shaped collection crossing suture lines | |||
**Chronic: hypodense, crescent-shaped; may have mixed density if rebleeding | |||
**Acute | **Evaluate for midline shift, mass effect, herniation | ||
**Chronic | *Labs: CBC, coagulation studies (PT/INR, PTT), type and screen | ||
** | *If on anticoagulation: specific reversal levels (e.g., anti-Xa for DOACs) | ||
==Management== | ==Management== | ||
* | ===Acute SDH=== | ||
*Emergent neurosurgical | *'''ABCs''' — intubate if GCS <=8 | ||
** | *'''Emergent neurosurgical consultation''' | ||
*'''Reverse anticoagulation''' immediately: | |||
** | **Warfarin: '''4-factor PCC''' (25-50 units/kg) + '''Vitamin K''' 10 mg IV | ||
** | **Dabigatran: '''Idarucizumab''' 5 g IV | ||
** | **Rivaroxaban/Apixaban: '''Andexanet alfa''' or '''4-factor PCC''' | ||
* | **Antiplatelet agents: platelet transfusion if surgical candidate | ||
* | *ICP management: head of bed elevation, osmotherapy ([[Mannitol]] or [[Hypertonic saline]]) | ||
** | *Surgical indications: clot thickness >10 mm, midline shift >5 mm, GCS drop >=2 points | ||
===Chronic SDH=== | |||
*Neurosurgical consultation for possible burr hole drainage | |||
*Reverse anticoagulation | |||
*Many small, asymptomatic chronic SDH may be observed with serial imaging | |||
*Symptomatic chronic SDH: typically surgical (burr hole or craniotomy) | |||
==Disposition== | ==Disposition== | ||
* | *All acute SDH: '''admit''', neurosurgical evaluation, ICU for operative or declining patients | ||
*Chronic SDH: admit if symptomatic, new, or enlarging; small stable chronic SDH may have outpatient neurosurgery follow-up | |||
==See Also== | ==See Also== | ||
*[[ | *[[Epidural hemorrhage]] | ||
*[[ | *[[Head trauma (main)]] | ||
*[[Subarachnoid hemorrhage]] | |||
*[[Anticoagulation reversal]] | |||
*[ | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Neurology]] | |||
[[Category:Trauma]] | [[Category:Trauma]] | ||
Revisión del 18:34 21 mar 2026
Background
- Bleeding between the dura mater and arachnoid membrane, typically from bridging vein rupture
- Three types by timing:
- Acute (<3 days) — hyperdense (white) on CT
- Subacute (3-21 days) — isodense (may be difficult to see)
- Chronic (>21 days) — hypodense (dark) on CT
- Most common in elderly and anticoagulated patients[1]
- Acute SDH mortality: 50-90% (highest of all traumatic intracranial lesions)
- May occur with minimal or no trauma in the elderly and anticoagulated
Risk Factors
- Advanced age (cerebral atrophy stretches bridging veins)
- Anticoagulation / antiplatelet therapy
- Chronic alcohol use (cerebral atrophy, coagulopathy)
- Coagulopathy or thrombocytopenia
- Prior falls or head trauma (even minor)
- CSF shunt (overdrainage)
Clinical Features
Acute SDH
- Headache, altered mental status, decreasing GCS
- Ipsilateral fixed/dilated pupil (uncal herniation)
- Contralateral hemiparesis
- May present with coma from onset
- Associated with high-energy mechanism or fall in anticoagulated patients
Chronic SDH
- Insidious onset over weeks to months
- Headache, cognitive decline, confusion, personality changes
- Gait disturbance, falls
- Fluctuating neurologic symptoms (may mimic stroke or dementia)
- History of trauma often absent or trivial
Differential Diagnosis
- Epidural hemorrhage
- Subarachnoid hemorrhage
- Intracerebral hemorrhage
- Ischemic stroke
- Meningitis
- Dementia (chronic SDH)
Evaluation
- Non-contrast CT head — test of choice[2]
- Acute: hyperdense, crescent-shaped collection crossing suture lines
- Chronic: hypodense, crescent-shaped; may have mixed density if rebleeding
- Evaluate for midline shift, mass effect, herniation
- Labs: CBC, coagulation studies (PT/INR, PTT), type and screen
- If on anticoagulation: specific reversal levels (e.g., anti-Xa for DOACs)
Management
Acute SDH
- ABCs — intubate if GCS <=8
- Emergent neurosurgical consultation
- Reverse anticoagulation immediately:
- Warfarin: 4-factor PCC (25-50 units/kg) + Vitamin K 10 mg IV
- Dabigatran: Idarucizumab 5 g IV
- Rivaroxaban/Apixaban: Andexanet alfa or 4-factor PCC
- Antiplatelet agents: platelet transfusion if surgical candidate
- ICP management: head of bed elevation, osmotherapy (Mannitol or Hypertonic saline)
- Surgical indications: clot thickness >10 mm, midline shift >5 mm, GCS drop >=2 points
Chronic SDH
- Neurosurgical consultation for possible burr hole drainage
- Reverse anticoagulation
- Many small, asymptomatic chronic SDH may be observed with serial imaging
- Symptomatic chronic SDH: typically surgical (burr hole or craniotomy)
Disposition
- All acute SDH: admit, neurosurgical evaluation, ICU for operative or declining patients
- Chronic SDH: admit if symptomatic, new, or enlarging; small stable chronic SDH may have outpatient neurosurgery follow-up
